SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Indications -- obesity/erectile dysfunction
An SI Board Since February 2001
Posts SubjectMarks Bans
435 30 0
Emcee:  scaram(o)uche Type:  Moderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
210Weight-loss drugs may harm developing brain: study By Julie Steenhuysen Wed Mayscaram(o)uche-5/8/2008
209Published online 6 May 2008 | Nature | doi:10.1038/news.2008.802 <b>Hungeidos-5/7/2008
208Published online 5 May 2008 | Nature | doi:10.1038/news.2008.800 <b>Fat cidos-5/6/2008
207fwiw, I have a Zafgen text file on my desktop (doing a little spring cleaning) IMike McFarland-5/5/2008
206Review; Nature Reviews Molecular Cell Biology 9, 367-377 (May 2008) Adipocyte dMike McFarland-5/5/2008
205Phase III Data Showed Taranabant, Merck's Investigational Medicine to Treat scaram(o)uche-3/31/2008
204medicine.plosjournals.org From the Editors' Summary of that study: <b&gidos-3/13/2008
203From The Sunday Times, February 10, 2008, by India Knight timesonline.co.uk &lidos-2/11/2008
202Endocrinology. 2007 Nov 26 [Epub ahead of print] Serotonin 5-HT2C Receptor Agonscaram(o)uche-1/7/2008
201Appetite Regulation Molecule Found: Could Lead To Treatments For Obesity And Unwsim1-11/6/2007
200<b>New bull's-eye for obesity fighting drugs</b> drugresearcheridos-10/13/2007
199HK experts warn against anti-impotence "remedies" Thu Oct 11, 2007 4:4Icebrg-10/11/2007
198NeuroSearch announces breakthrough tesofensine results from clinical Phase IIb snigel bates-9/17/2007
197VERNALIS ANNOUNCES STRIKING WEIGHT LOSS IN PHASE I STUDY WITH V24343 IN Onigel bates-9/13/2007
196Behav Pharmacol. 2007 Sep;18(5-6):431-8. Local enhancement of cannabinoid CB1 rscaram(o)uche-9/7/2007
195'Skinny Gene' Exists Source: UT Southwestern Medical Center Date: Sesim1-9/5/2007
194Neurogastroenterol Motil. 2007 Sep;19(9):744-53. Cannabinoid type 1 receptor moscaram(o)uche-9/1/2007
193Neuropharmacology. 2007 Jul 19; [Epub ahead of print] Reduced anxiety-like behascaram(o)uche-8/22/2007
192FASEB J. 2007 Aug 17; [Epub ahead of print] The cannabinoid CB1 receptor regulascaram(o)uche-8/21/2007
191Am J Physiol Endocrinol Metab. 2007 Jun 26; [Epub ahead of print] The CB1 recepscaram(o)uche-7/6/2007
190Science. 2007 Jun 8;316(5830):1494-7. Attenuation of allergic contact dermatitscaram(o)uche-6/27/2007
189Neuroscientist. 2007 Apr;13(2):127-37. Endocannabinoids and synaptic function scaram(o)uche-4/4/2007
188J Med Chem. 2007 Feb 23; [Epub ahead of print] Discovery of (R)-9-Ethyl-1,3,4,scaram(o)uche-2/26/2007
187Sanofi-Aventis: FDA Lays to Rest Metabolic Syndrome Indication for Acomplia PostLJM-2/20/2007
186Sanofi says FDA delays weight-loss drug decision Mon Feb 12, 2007 6:20pm ET NEWscaram(o)uche-2/12/2007
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News